Summit Cancer Care
Summit Cancer Care is a private, physician-owned medical oncology and hematology practice in Savannah, Georgia, operating five Coastal Empire locations. Nine board-certified physicians deliver chemotherapy, immunotherapy, targeted therapy, hematology care, and clinical trials under hospital-system billing arrangements.
- Company typePrivate
- Founded1983
- HeadquartersSavannah, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Summit Cancer Care does
Summit Cancer Care, P.C. is a private, physician-owned medical oncology and hematology practice headquartered in Savannah, Georgia, serving the Coastal Empire region of southeastern Georgia and adjacent South Carolina. Founded in 1976 and operating for more than 40 years, the practice is staffed by 9 board-certified physicians and delivers non-surgical cancer treatment (chemotherapy, immunotherapy, targeted therapy, hormonal therapy), hematology services for blood cancers and non-malignant blood disorders, an in-house specialty pharmacy dispensing oral oncology and supportive care medications, participation in NCI-affiliated clinical trials, and supportive services such as financial counseling and on-site lab testing. Across its portfolio it treats breast, lung, colorectal, head and neck, bladder, prostate, liver, pancreatic, sarcoma, kidney, and testicular cancers, alongside leukemias, lymphomas, and multiple myeloma.
The practice operates from five clinical locations — Savannah (Cancer & Research Pavilion and Medical Arts/Pharmacy), Statesboro, Pembroke, and Springfield (Effingham County) in Georgia, with oncology-certified nursing coverage extending into Bluffton, South Carolina. Service delivery is partnership-anchored: clinical space is co-located with St. Joseph's/Candler Health System and Effingham Health System, and billing runs through those hospital partners (St. Joseph's/Candler for Savannah/Pembroke/Statesboro; Effingham Health System for Effingham). The go-to-market model is referral-driven rather than consumer-advertised: new patients enter via a formal physician referral process with dedicated fax lines, referral forms, and New Patient Coordinators at each site. In May 2025 Summit joined the American Oncology Network (AON), giving it access to FDA-approved radioligand therapies (Pluvicto, Lutathera, Xofigo) and adding a high-value therapeutic modality to its community oncology offering.
Revenue is professional-services based, generated through hospital-system billing arrangements and the in-house specialty pharmacy; the practice is privately held with no disclosed funding rounds, no parent company, and no public revenue figures. Differentiation rests on credentialed physician talent (training at Harvard, M.D. Anderson, Stanford, Baylor, Emory, Medical College of Georgia), NCI-linked clinical research participation, 40+ years of regional brand equity, and hospital system co-location. The practice operates as a buy-side/hold-steady independent community oncology asset rather than a venture-backed growth company.
Summit Cancer Care firmographics
Firmographics- Name
- Summit Cancer Care
- Legal name
- Summit Cancer Care, P.C.
- Website
- https://summitcancercare.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Summit Cancer Care is a private, physician-owned medical oncology and hematology practice in Savannah, Georgia, operating five Coastal Empire locations. Nine board-certified physicians deliver chemotherapy, immunotherapy, targeted therapy, hematology care, and clinical trials under hospital-system billing arrangements.
- Ownership category
- akta.pro rank
Summit Cancer Care industry classification
Industry- Product category
- Community Oncology and Hematology Services
- NAICS
- Offices of Physicians (62111), Ambulatory Health Care Services (621)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
Keywords
Where Summit Cancer Care is headquartered
LocationHeadquarters
- HQ city
- Savannah
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Summit Cancer Care business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain, Technology or R&D
Revenue model
- Medical Services Revenue: Summit Cancer Care physicians provide medical oncology and hematology services billed through health system partners based on location. Services in Savannah, Pembroke, and Statesboro are billed by St. Joseph's Candler Health System. Services in Effingham are billed by Effingham Health System. The practice also operates an in-house specialty pharmacy for oral cancer medications and supportive care drugs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Medical oncology and hematology services billed through health system partners |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels2 records
Summit Cancer Care product offering
Product offeringCore offering
Summit Cancer Care is a private medical oncology and hematology practice that diagnoses and treats cancer and blood disorders through chemotherapy, immunotherapy, targeted therapy, and hormonal therapy, alongside a clinical trials program and an in-house specialty pharmacy. Services are delivered by board-certified oncologists and hematologists across five locations in the Coastal Empire region of Georgia, with billing routed through affiliated health systems (St. Joseph's/Candler and Effingham Health System).
Product overview
Summit Cancer Care is a medical oncology and hematology practice offering a unified suite of services centered on non-surgical cancer and blood disorder treatment. The core offerings include Cancer Treatment Services (chemotherapy, immunotherapy, targeted therapy, hormonal therapy), Hematologic Disorder Care, and a Clinical Trials Program. Supporting these are an In-House Specialty Pharmacy providing oral medications and supportive care, Financial Counseling and Assistance, and Symptom/Side Effect Management services. All services are delivered across multiple Georgia locations through physicians who work with surgeons and radiation oncologists for coordinated care.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Treatment Services Comprehensive non-surgical cancer treatment including chemotherapy, immunotherapy, targeted therapy, and hormonal therapy for various cancers such as breast, lung, colorectal, head and neck, bladder, prostate, liver, pancreatic, sarcoma, kidney, and testicular cancers, delivered through IV infusion, injection, or oral administration at multiple clinic locations.
- Hematologic Disorder Care Diagnosis and treatment of blood cancers including leukemia, lymphoma, and multiple myeloma, as well as non-cancerous blood disorders such as polycythemia vera, hereditary hemochromatosis, anemia, hemophilia, thrombocytopenia, clotting disorders, and white blood cell abnormalities, supported by in-office iron infusions, therapeutic infusions, and blood transfusions.
- Clinical Trials Program Participation in clinical trials providing patients access to the latest and broadest range of treatment options, including research trials with the National Cancer Institute brought to the St. Joseph's/Candler System.
- In-House Specialty Pharmacy Oncology-experienced in-house pharmacy providing oral cancer medications, supportive care drugs, and over-the-counter items for chemotherapy side effects, with drive-through pickup and clinical pharmacy program oversight at satellite offices staffed by an oncology-trained pharmacist.
- Radioligand Therapy Advanced radioligand therapy delivery enabled through the American Oncology Network partnership, offering FDA-approved Pluvicto for metastatic prostate cancer, Lutathera for neuroendocrine tumors, and Xofigo for bone metastases, with over 300 treatments delivered to nearly 70 patients through the partnership.
- Symptom and Side Effect Management Ongoing symptom management and side effect support for patients undergoing treatment, including central line and port care, on-site lab testing, and blood draws delivered by oncology-certified nursing staff.
- Financial Counseling and Assistance Financial counseling and assistance services to help patients manage costs associated with cancer and blood disorder treatments.
Quantifiable outcome
- Over 300 radioligand treatments delivered to nearly 70 patients through American Oncology Network partnership
Companies that use Summit Cancer Care
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles1 record
Summit Cancer Care technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Summit Cancer Care partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- American Oncology Network (AON)coreSummit Cancer Care is one of six community oncology practice partners in the American Oncology Network. Through this partnership, the practice offers advanced radioligand therapies including FDA-approved Pluvicto (metastatic prostate cancer), Lutathera (neuroendocrine tumors), and Xofigo (bone metastases). Over 300 treatments have been delivered to nearly 70 patients through this network.
Scale indicators5 records
Recent moves5 records
Expansion highlights4 records
Summit Cancer Care competitors and assessment
Company assessmentBroad incumbents
- OneOncology: PE-backed national platform partnering with community oncology practices to provide capital, technology, and operational support. Comparable community oncology service mix and patient base; represents both a peer and a potential acquirer/affiliation option for independent practices like Summit.
- US Oncology Network (McKesson): Nationwide network of community oncology practices supported by McKesson, providing drug distribution, technology, and contracting infrastructure. Comparable end-customer service line (community medical oncology) but operates as an enabling platform rather than a single physician-owned practice.
- City of Hope: Major NCI-designated cancer center with extensive community oncology footprint (including acquired Cancer Treatment Centers of America). Overlapping oncology and hematology service lines and clinical trials capabilities, but operates at academic/institutional scale rather than as an independent community practice.
Direct peers
- Northwest Medical Specialties (NMS): Community-based oncology and hematology practice in the Pacific Northwest offering chemotherapy, immunotherapy, infusion, and specialty pharmacy. Comparable multi-site community oncology model with similar physician ownership and specialty pharmacy integration.
- American Oncology Network (AON): Summit Cancer Care is one of six community oncology practice partners of AON. AON provides centralized services (including access to advanced radioligand therapies like Pluvicto and Lutathera) to community oncology practices — directly comparable business model and service scope.
- Florida Cancer Specialists & Research Institute: Largest physician-owned community oncology/hematology practice in the U.S., offering chemotherapy, immunotherapy, clinical trials, and specialty pharmacy across Florida. Directly comparable physician-owned, multi-site model with clinical trials and specialty pharmacy integration.
- Texas Oncology: Large community oncology practice network offering medical oncology, hematology, and radiation oncology across Texas. Closely mirrors Summit's physician-owned community oncology model but at significantly greater scale; useful for benchmarking multi-site community oncology operations.
- Tennessee Oncology: Community-based oncology and hematology practice with multiple locations across Tennessee, offering medical oncology, infusion, clinical trials, and specialty pharmacy. Comparable multi-site community oncology model with similar service mix and physician-owned structure.
- Maryland Oncology Hematology: Community oncology and hematology practice group serving the Mid-Atlantic region, offering chemotherapy, immunotherapy, clinical trials, and specialty pharmacy. Recently affiliated with OneOncology platform; comparable regional community oncology service mix and patient base.
- The Oncology Institute: Publicly-traded community oncology practice with multi-site medical oncology, hematology, and specialty pharmacy across multiple states. Comparable core services (chemotherapy, immunotherapy, specialty pharmacy) and value-based care orientation, but at materially larger scale.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Summit Cancer Care social profiles
Digital presenceSummit Cancer Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Summit Cancer Care leadership team
Management profileNumber of profiles
Profiles9 records
Summit Cancer Care funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Summit Cancer Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Summit Cancer Care
What does Summit Cancer Care do?
Summit Cancer Care is a private medical oncology and hematology practice that diagnoses and treats cancer and blood disorders through chemotherapy, immunotherapy, targeted therapy, and hormonal therapy, alongside a clinical trials program and an in-house specialty pharmacy. Services are delivered by board-certified oncologists and hematologists across five locations in the Coastal Empire region of Georgia, with billing routed through affiliated health systems (St. Joseph's/Candler and Effingham Health System).
Is Summit Cancer Care a public or private company?
Summit Cancer Care is a private company. It is classified as management employee owned and is currently operating.
When was Summit Cancer Care founded?
Summit Cancer Care was founded in 1983. It employs 11 to 50 people.
Where is Summit Cancer Care based?
Summit Cancer Care is headquartered in Savannah, United States, in the North America region.
How does Summit Cancer Care make money?
One revenue line is on record: medical Services Revenue.
Who are Summit Cancer Care's main competitors?
Broad incumbents on record are OneOncology, US Oncology Network (McKesson) and City of Hope. Direct peers are Northwest Medical Specialties (NMS), American Oncology Network (AON), Florida Cancer Specialists & Research Institute, Texas Oncology, Tennessee Oncology, Maryland Oncology Hematology and The Oncology Institute.
Does Summit Cancer Care have an API?
No public API is recorded for Summit Cancer Care.
What industry is Summit Cancer Care in?
Summit Cancer Care's product category is Community Oncology and Hematology Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.